STAT

SEPTEMBER 18, 2024

patent system by the pharmaceutical industry, moves by some drugmakers to expand their patent claims appear to be delaying the arrival of lower-cost generic medicines to the marketplace, according to a STAT analysis.  Amid debate over potential abuse of the U.S.

Generic Medicine 141

Generic Medicine 141

STAT

SEPTEMBER 14, 2023

In explaining its new policy statement , the FTC noted that some drug companies have failed to follow requirements for listing patents in the so-called Orange Book in hopes of thwarting competition from lower-cost generic medicines. Continue to STAT+ to read the full story…

Generic Medicine 127

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies FDA 127

STAT

NOVEMBER 7, 2023

The move comes two months after the FTC issued a policy statement noting some drug companies have failed to follow requirements for listing patents in the Food and Drug Administration’s Orange Book in hopes of thwarting competition from lower-cost generic medicines. Continue to STAT+ to read the full story…

Generic Medicine 116

Generic Medicine 116

The Checkup by Singlecare

OCTOBER 12, 2023

This is because generic medicines are much less expensive than their brand-name counterparts, even though they work just as well. What are the differences between brand name and generic Abilify? Aripiprazole was approved by the FDA in 2015. Aripiprazole is widely available at pharmacies across the U.S.

Dosage 52

Dosage Labelling FDA Adverse Reactions 52